SCYNEXIS, Inc. Increase (Decrease) in Restructuring Reserve
SCYNEXIS, Inc. (SCYX) reported Increase (Decrease) in Restructuring Reserve of $0 for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestructuringReserve · last filed 2018-03-13
- SCYNEXIS, Inc. increase (decrease) in restructuring reserve for the quarter ending 2017-09-30 was $0.00.
- SCYNEXIS, Inc. increase (decrease) in restructuring reserve for the quarter ending 2017-06-30 was $0.00.
- SCYNEXIS, Inc. increase (decrease) in restructuring reserve for the quarter ending 2017-03-31 was $0.00.
- SCYNEXIS, Inc. increase (decrease) in restructuring reserve for the quarter ending 2016-12-31 was -$8.00K.
- SCYNEXIS, Inc. increase (decrease) in restructuring reserve for fiscal 2016 was -$2.64M.
| Period end | Increase (Decrease) in Restructuring Reserve 3 month | Increase (Decrease) in Restructuring Reserve 6 month | Increase (Decrease) in Restructuring Reserve 9 month | Increase (Decrease) in Restructuring Reserve 12 month |
|---|---|---|---|---|
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | -$8.00K derived: sum of 4 quarters · filed 2018-03-13 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $0.00 10-Q · filed 2017-08-08 | -$8.00K derived: sum of 3 quarters · filed 2018-03-13 | -$220.00K derived: sum of 4 quarters · filed 2018-03-13 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-08 | -$8.00K derived: sum of 2 quarters · filed 2018-03-13 | -$220.00K derived: sum of 3 quarters · filed 2018-03-13 | -$830.00K derived: sum of 4 quarters · filed 2018-03-13 |
| 2016-12-31 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | -$220.00K derived: sum of 2 quarters · filed 2018-03-13 | -$830.00K derived: sum of 3 quarters · filed 2018-03-13 | -$2.64M 10-K · filed 2018-03-13 |
| 2016-09-30 | -$212.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$822.00K derived: sum of 2 quarters · filed 2017-11-07 | -$2.63M 10-Q · filed 2017-11-07 | |
| 2016-06-30 | -$610.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$2.42M 10-Q · filed 2017-08-08 | ||
| 2016-03-31 | -$1.81M 10-Q · filed 2017-05-08 | |||
| 2015-09-30 | $1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $2.81M derived: sum of 2 quarters · filed 2016-11-07 | $2.81M 10-Q · filed 2016-11-07 | |
| 2015-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $1.50M 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-09 | |||
| 2014-09-30 | -$389.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $0.00 10-Q · filed 2015-11-13 | ||
| 2014-06-30 | $389.00K 10-Q · filed 2015-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |